CELL AND GENE THERAPY CATAPULT
Ribosome profiling of suspension-adapted HEK293 cells producing adeno-associated viruses
The procurement contact named on the official notice.
Services for the ribosome profiling of suspension-adapted human cells producing an adeno-associated virus (AAV) vector.Human cells will be subjected to AAV production in parallel with controls.
A range of samples (between 21 and 35) will be generated in this experiment, designated as "Run 1".
The samples will then be processed by the awarded Bidder.
In addition to "Run 1", two additional runs ("Run 2" and "Run 3") may be performed at our sole discretion.
Importantly, the experimental setup for both "Run 2" and "Run 3" will be similar to that for "Run 1", but sample numbers may differ if additional conditions are included or excluded.
A maximum of 35 samples will be obtained for either "Run 2" and "Run 3".
Make the case to bid
Reveal who to approach at CELL AND GENE THERAPY CATAPULT, and generate a go-to-market strategy from their news, accounts and people.
- OCID
- ocds-h6vhtk-034db7
- Stage
- award · Awarded
- Source
- Find a Tender
- Buyer ref
- 025600-2022
Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.
Who wins this kind of work
The suppliers and buyers around this opportunity — drawn from official award data. Drag to orbit; click a node to explore.
Top suppliers & buyers in Research & Development
Assembling the market network…
CELL AND GENE THERAPY CATAPULT’s tender network
Assembling the network…